| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0960-894X(00)00430-3 |
| P698 | PubMed publication ID | 11012026 |
| P2093 | author name string | Hofmann HP | |
| Möller A | |||
| Lubisch W | |||
| Treiber HJ | |||
| P2860 | cites work | Structure and physiological function of calpains | Q24530607 |
| Six-hour window of opportunity for calpain inhibition in focal cerebral ischemia in rats | Q36895149 | ||
| Cell-penetrating inhibitors of calpain | Q37260529 | ||
| Calpain inhibition: an overview of its therapeutic potential | Q40592886 | ||
| Exploration of the importance of the P2-P3-NHCO-moiety in a potent di- or tripeptide inhibitor of calpain I: insights into the development of nonpeptidic inhibitors of calpain I. | Q41033620 | ||
| Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases | Q42553698 | ||
| Role of Calpain in Spinal Cord Injury: Effects of Calpain and Free Radical Inhibitorsa | Q47671491 | ||
| A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy | Q48284517 | ||
| Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα/NF-κB pathway in limb-girdle muscular dystrophy type 2A | Q57398233 | ||
| Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins | Q70250641 | ||
| Stereospecific synthesis of peptidyl alpha-keto amides as inhibitors of calpain | Q72153804 | ||
| Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases | Q72579390 | ||
| P2-proline-derived inhibitors of calpain I | Q77749430 | ||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 2187-2191 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors | |
| P478 | volume | 10 |
| Q47135149 | Antiepileptic and Neuroprotective Effects of Oleamide in Rat Striatum on Kainate-Induced Behavioral Seizure and Excitotoxic Damage via Calpain Inhibition |
| Q39661641 | Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion |
| Q37857282 | Calpain inhibitors: a survey of compounds reported in the patent and scientific literature |
| Q43981452 | Discovery of phenyl alanine derived ketoamides carrying benzoyl residues as novel calpain inhibitors |
| Q45256092 | Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors. |
| Q35076795 | Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response |
| Q44011778 | Exploration of peptidyl hydrazones as water-soluble calpain inhibitors |
| Q37812402 | Physiologic and pathophysiologic role of calpain: implications for the occurrence of atrial fibrillation |
| Q34754642 | Recent advances in the synthesis, design and selection of cysteine protease inhibitors |
Search more.